The Union Ministry of Commerce and Industry has imposed a Minimum Import Price (MIP) on three key active pharmaceutical ingredients—penicillin and its salts, amoxycillin and its salts, and 6-aminopenicillanic acid (6-APA)—for a period of one year.
Swati Patel, Manager, Allpharm discusses with Pharma Industrial India how the company is driving adoption of South Korean pharmaceutical machinery in India through competitive pricing, versatile solutions and robust...
Rahul Jaiswal, Account Manager–India, MA micro automation, explains to Pharma Industrial India how the Germany-based company is establishing its footprint in India, emphasising the growing demand for quality-f...
Prasad Gupta, Senior Manager- Marketing, Standard Group of Companies, in an exclusive interview, shares insights with Pharma Industrial India, about the innovative approach to pharmaceutical machinery, highlighting ...
Discipline has become the real competitive advantage in generic pharmaceuticals, overtaking scale, speed and low cost as the main drivers of success....
Falgun Jani, Business Head – India, Freudenberg Medical, explores the growing role of Single-use Systems (SUS) in enabling sustainable pharmaceutical manufacturing, highlighting their economic advantages, oper...
India’s pharmaceutical industry is transitioning from a reactive, volume-driven model to a predictive, AI-powered ecosystem—highlighting the role of agentic AI, smart manufacturing, resilient supply chai...
By Darshana Daga
By Pharma Industrial India
Latest news in...
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy